Literature DB >> 7570957

The main infiltrating cell in xenograft rejection is a CD4+ macrophage and not a T lymphocyte.

A C Wallgren1, A Karlsson-Parra, O Korsgren.   

Abstract

Porcine fetal islet-like cell clusters (ICC) or isolated rat islets were implanted under the kidney capsule of normoglycemic rats. The animals were sacrificed 1, 3, 6, 12, or 24 days after transplantation, and a detailed morphological and phenotypic characterization of the different cellular subtypes infiltrating the xenograft was performed and compared with the rejection of allogeneic islets. In xenograft rejection a progressive infiltration of large, polygonal, macrophage-like cells, which with time became the dominating cellular subtype, occurred. These cells expressed the CD4 antigen and the macrophage-specific ED1 antigen. From day 6 and onward, a majority of the macrophage-like cells also expressed the CD8 antigen and the macrophage-specific differentiation antigen ED2. T lymphocytes, defined by their TCR alpha/beta or CD2 expression, were found in low numbers and mainly in the periphery of the graft. At the later stages of xenorejection a substantial number of eosinophilic granulocytes were also found. The allograft rejection, on the contrary, was characterized by a progressive infiltration of T lymphocytes, which with time became the dominating cellular subtype. No clear immunoglobulin or complement deposition was seen in the transplants before day 12, when IgG deposition was found in central necrotic areas of the xenograft. Previous experiments in rodents have underlined the crucial importance of CD4 positive cells in the xenograft rejection process. However, in none of these studies it was conclusively demonstrated that the CD4-expressing cells were T lymphocytes. The presence of CD4-expressing macrophages heavily infiltrating the porcine xenograft seen in our study may thus be in agreement with previous studies in which the anti-CD4 reactive cells were erroneously designated T lymphocytes. Interestingly, the findings in xenograft rejection in the present study have striking similarities with the defense mechanisms active against infections by large parasites such as helminths.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7570957     DOI: 10.1097/00007890-199509270-00013

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  16 in total

1.  A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson's disease.

Authors:  R A Barker; E Ratcliffe; M McLaughlin; A Richards; S B Dunnett
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

Review 2.  CD47 in xenograft rejection and tolerance induction.

Authors:  Yong-Guang Yang
Journal:  Xenotransplantation       Date:  2010 Jul-Aug       Impact factor: 3.907

Review 3.  CD47: a new player in phagocytosis and xenograft rejection.

Authors:  Nalu Navarro-Alvarez; Yong-Guang Yang
Journal:  Cell Mol Immunol       Date:  2011-01-24       Impact factor: 11.530

Review 4.  Immunological challenges and therapies in xenotransplantation.

Authors:  Marta Vadori; Emanuele Cozzi
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

5.  First experience with the use of a recombinant CD3 immunotoxin as induction therapy in pig-to-primate xenotransplantation: the effect of T-cell depletion on outcome.

Authors:  Hiroaki Nishimura; Joseph Scalea; Zhirui Wang; Akira Shimizu; Shannon Moran; Bradford Gillon; David H Sachs; Kazuhiko Yamada
Journal:  Transplantation       Date:  2011-09-27       Impact factor: 4.939

6.  Immunoprotective properties of primary Sertoli cells in mice: potential functional pathways that confer immune privilege.

Authors:  Timothy J Doyle; Gurvinder Kaur; Saroja M Putrevu; Emily L Dyson; Mathew Dyson; William T McCunniff; Mithun R Pasham; Kwan Hee Kim; Jannette M Dufour
Journal:  Biol Reprod       Date:  2012-01-10       Impact factor: 4.285

7.  Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.

Authors:  C Gysemans; K Stoffels; A Giulietti; L Overbergh; M Waer; M Lannoo; U Feige; C Mathieu
Journal:  Diabetologia       Date:  2003-07-17       Impact factor: 10.122

Review 8.  Application of xenogeneic stem cells for induction of transplantation tolerance: present state and future directions.

Authors:  Yong-Guang Yang
Journal:  Springer Semin Immunopathol       Date:  2004-09-11

9.  Pseudorabies virus-induced leukocyte trafficking into the rat central nervous system.

Authors:  S Rassnick; L W Enquist; A F Sved; J P Card
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 10.  Current status of xenotransplantation and prospects for clinical application.

Authors:  Richard N Pierson; Anthony Dorling; David Ayares; Michael A Rees; Jörg D Seebach; Jay A Fishman; Bernhard J Hering; David K C Cooper
Journal:  Xenotransplantation       Date:  2009 Sep-Oct       Impact factor: 3.907

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.